Effects of Backward Gait Training with Exoskeleton on Motor Functions

Last updated: October 3, 2024
Sponsor: Alvernia University
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Gait training with EksoNR

Backward gait training with EksoNR

Clinical Study ID

NCT05133362
IRB 052-21
  • Ages > 18
  • All Genders

Study Summary

The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function.

AIM 2 is to investigate the effect of backward gait training with exoskeleton on depression.

AIM 3 is to investigate the impact of social determinants of health and depression on patient adherence to physical therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years of age or older

  • English or Spanish speaking

  • A diagnosis first stroke (intracerebral hemorrhage or acute ischemic stroke)

  • Referred to Reading Rehabilitation Hospital Outpatient Physical Therapy Clinic (hereafter referred to as outpatient PT)

Exclusion

Exclusion Criteria:

  • Unable to follow 1-step commands

  • > 220 pounds (100 kg)

  • Height < 5'0" or > 6'4"

  • Unable to take a few steps with assistance

  • A score of > 42/56 on Berg Balance Scale (BBS)

  • Severe cardiac disease (New York Heart Association Classification IV)

  • Severe spasticity (Modified Ashworth score > 3)

  • Unstable spine or unhealed pelvic/limb fractures

  • Active heterotrophic ossification impacting lower extremity range of motion

  • Significant lower or upper extremity contractures

  • Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion

  • Psychiatric or cognitive issues that could interfere with operating the exoskeleton

  • Pregnancy

  • Colostomy

  • Poor skin integrity in areas in contact with the EksoNRTM

  • Unresolved deep vein thrombosis

  • Lower limb prosthesis or amputation

  • Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs

  • ROM restrictions preventing normal, reciprocal gait

  • Inability to stand for > 60 seconds due to pain or orthostatic hypotension

Study Design

Total Participants: 9
Treatment Group(s): 2
Primary Treatment: Gait training with EksoNR
Phase:
Study Start date:
August 25, 2022
Estimated Completion Date:
September 30, 2024

Study Description

Based on previous findings on backward gait training as well as the use of a wearable robotic exoskeleton in forward gait training, we hypothesize that backward gait training using exoskeleton leads to greater improvements in functional mobility, neuromuscular control and balance (AIM 1) and depression (AIM 2) in patients with stroke, when compared to standard of care, which includes forward gait training using exoskeleton. Findings from AIM 1 and 2 will provide novel evidence on the effects of backward gait training with exoskeleton in people with stroke and serve as a foundation for optimizing physical therapy protocols to improve motor functions and mental health. AIM 3 investigates the impact of social determinants of health and depression on patient adherence to physical therapy. Patient adherence (also called compliance) refers to the degree to which patients follow treatment recommendations prescribed by their health care provider.34 Even though patient adherence leads to positive treatment outcomes,35,36 it is affected by many factors, including patients' understanding of their disease and associated treatment (i.e., health literacy), social support, and depression.36-38 This experimental study employs a repeated measures design with participants randomly assigned to either a Standard Care with Ekso Group (SCG; control group, n=31) or a Standard Care with Ekso and Backward Walking Group (SCBWG; experimental group, n=31) in AIMs 1 and 2. AIMs 1 and 2 will be achieved using the group assignment as independent variables and motor function and depression as dependent variables. AIM 3 will be achieved using social determinants of health and depression as independent variables and patient adherence to physical therapy as an independent variable.

Connect with a study center

  • Sunnyview Rehabilitation Hospital

    Schenectady, New York 12308
    United States

    Site Not Available

  • Reading Hospital Rehabilitation at Wyomissing

    Reading, Pennsylvania 19610
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.